破裂性与择期腹主动脉瘤EVAR中期结果比较
该回顾性队列研究纳入2000至2015年单中心接受EVAR的565例患者(r-EVAR 65例,el-EVAR 500例),比较两者中期结局。结果显示r-EVAR组住院期并发症和再干预更多,但出院后5年免于AAA相关并发症、颈相关事件、二次干预及生存率两组无显著差异;超出近端锚定区IFU是颈相关事件的独立危险因素。
要点
- r-EVAR住院期并发症(12.3% vs 3.2%)和再干预(12.3% vs 2.8%)显著高于el-EVAR。
- 出院后5年免于AAA相关并发症、颈相关事件、二次干预及生存率两组无显著差异。
- 超出近端锚定区IFU显著增加颈相关事件风险(r-EVAR HR 6.5,el-EVAR HR 2.6)。
核心结论
- 存活出院的r-EVAR和el-EVAR患者均获得持久的中期结局。
- 超出IFU治疗的患者晚期并发症风险更高。
- Surveillance方案可根据个体解剖和IFU依从性而非修复时机制定。
研究设计与样本
- 回顾性队列分析,纳入2000至2015年单中心接受EVAR的患者。
- 排除既往主动脉手术、非动脉粥样硬化性AAA、孤立性髂动脉瘤、院内死亡及中转开放手术者。
- 中期分析仅纳入至少两次术后检查(30天CT和6个月或以后)的患者。
- 共纳入565例患者,其中r-EVAR 65例,el-EVAR 500例。
主要发现
- r-EVAR组住院期并发症12.3% vs el-EVAR 3.2%(P = .001),再干预12.3% vs 2.8%(P < .001)。
- 5年免于AAA相关并发症:r-EVAR 53.9% vs el-EVAR 65.4%(P = .21)。
- 多变量分析中r-EVAR组晚期并发症风险未增加(HR 0.94;95%CI 0.54-1.61;P = .81)。
- 5年免于颈相关事件:r-EVAR 74% vs el-EVAR 82%(P = .345)。
- 超出近端锚定区IFU者颈相关事件风险增加:r-EVAR组HR 6.5(95%CI 1.8-22.9;P = .004),el-EVAR组HR 2.6(95%CI 1.5-4.5;P < .001)。
关键数值与推荐
- 主要终点为免于AAA相关并发症(复合I/III型内漏、瘤囊增大、移位>5 mm、装置完整性失败、AAA相关死亡、晚期破裂或AAA相关二次干预)。
- 次要终点包括免于二次干预、颈相关事件(复合IA型内漏、移位>5 mm或预防性颈相关二次干预)和晚期生存。
- 评估装置IFU依从性对颈事件的影响。
临床怎么用
- r-EVAR患者出院后中期结局与el-EVAR相当,应注重术后监测。
- 应严格评估近端锚定区IFU依从性,超出IFU者需加强随访。
- 监测方案可基于个体解剖和IFU依从性制定,而非修复时机。
局限性
- 回顾性单中心研究设计。
- 中期分析仅纳入完成至少两次术后检查的患者,可能存在选择偏倚。
- r-EVAR组样本量较小(65例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular aneurysm repair (EVAR) became an increasingly preferred modality for abdominal aortic aneurysm (AAA) repair both in elective AAA repair (el-EVAR) and EVAR of a ruptured AAA (r-EVAR) setting. Ruptured AAAs usually have more hostile anatomies and less time for planning. Consequently, more complications may arise after r-EVAR. The purpose of this study was to compare mi-term outcomes between r-EVAR and el-EVAR. METHODS: A retrospective cohort analysis of patients undergoing EVAR from 2000 to 2015 at a tertiary institution was performed. Patients with previous aortic surgery, nonatherosclerotic AAA and isolated iliac aneurysms were excluded. In-hospital casualties or patients who were intraoperatively converted to open repair were also excluded. For the midterm outcome analysis, only patients with at least two postoperative examinations (a 30-day computed tomography scan and a second postoperative examination performed 6 months or later) were considered. The primary end point was freedom from aneurysm-related complications (a composite of type I or III endoleak, aneurysm sac growth, migration of more than 5 mm, device integrity failure, AAA-related death, late postimplant rupture, or AAA-related secondary intervention). Freedom from secondary interventions, neck-related events (defined as a composite of type IA endoleak, migration of more than 5 mm, or preemptive neck-related secondary intervention) and late survival were secondary end points. The impact of device instructions for use (IFU) compliance on neck events was also assessed. RESULTS: The study included 565 patients (65 r-EVAR and 500 el-EVAR). Eighty-two patients were treated outside proximal neck IFU, 13 in the r-EVAR group (21.3%) and 69 (14.5%) in the el-EVAR (P = .16). During the index hospitalization, there were more complications (12.3% vs 3.2%; P = .001) and reinterventions (12.3% vs 2.8%; P < .001) in the r-EVAR group. After discharge, median clinical follow-up time was 4.3 years (interquartile range, 2.1-7.0 years) without differences between both groups. Five-year freedom from AAA-related complications was 53.9% in the r-EVAR group and 65.4% in the el-EVAR (P = .21). In multivariable analysis the r-EVAR group was not at increased risk for late complications (hazard ratio [HR], 0.94; 95% confidence interval [CI], 0.54-1.61; P = .81). Five-year freedom from neck-related events was 74% in r-EVAR and 82% in the el-EVAR group (P = .345). Patients treated outside neck IFU were at greater risk for neck-related events both in r-EVAR (HR, 6.5; 95% CI, 1.8-22.9; P = .004) and el-EVAR group (HR, 2.6; 95% CI, 1.5-4.5; P < .001). Freedom from secondary interventions at 5 years was 63.0% for r-EVAR and 76.9% for el-EVAR (P = .16). Survival at 5 years was 68.8% in the r-EVAR group and 73.3% in the el-EVAR group (P = .30). CONCLUSIONS: Durable and sustainable midterm outcomes were found for both r-EVAR and el-EVAR patients who survived the postoperative period. Patients treated outside the IFU are at greater risk for late complications. Surveillance protocols may be tailored according to individual anatomy and IFU compliance rather than timing of repair.
引用
- Oliveira-Pinto J, Soares-Ferreira R, Oliveira NFG, et al. Comparison of midterm results of endovascular aneurysm repair for ruptured and elective abdominal aortic aneurysms. J Vasc Surg. 2019. PMID: 31677942. doi:10.1016/j.jvs.2019.07.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。